Waverley Pharma Competitors and Similar CompaniesClear all
Puma Biotechnology's competitors and similar companies include Progenics Pharmaceuticals and Biocon.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  Progenics Pharmaceuticals Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients. | ||
Founding Date | Founding Date 2010 | Founding Date 1986 | Founding Date 1978 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Los Angeles, US HQ | Locations New York, US HQ Billerica, US | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more |
Employees | Employees 27214% decrease | Employees 49 | Employees 16,5612% increase |
Financial | |||
Revenue (est.) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $35m (FY, 2019) | Revenue (est.) ₹167.8b (FY, 2026) |
Cost of goods | Cost of goods $58.2m (FY, 2025) | Cost of goods $3.2m (FY, 2019) | Cost of goods ₹56.9b (FY, 2026) |
Gross profit | Gross profit $170.2m (FY, 2025) | Gross profit $31.8m (FY, 2019) | Gross profit ₹115.8b (FY, 2026) |
Net income | Net income N/A | Net income ($68.6m) (FY, 2019) | Net income ₹3.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Progenics Pharmaceuticals
HQ
New York, US
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View company